Indonesia Healthcare Market Outlook to 2022

By Hospitals, Clinical Laboratories, Pharmaceutical, Pharmacy Chains, Medical Device Segment

Region:Asia

Product Code:KR586

Download Sample Report

Published On

February 2018

Total pages

362

Table of Content

Market Overview
Scope Of The Report
Product covered
Table Of Content
Research Methodology
FAQs

Download Sample Report

About the Report

Click Here for Updated Report on

The report titled "Indonesia Healthcare Market Outlook to 2022 - by Hospitals, Clinical Laboratories, Pharmaceutical, Pharmacy Chains, Medical Device Segment" provides information on market size for Indonesia Healthcare, hospital, pharmaceutical, pharmacy retail, clinical laboratory and medical devices. The report covers aspects such as healthcare market segment (by hospitals, pharmaceuticals, medical devices and clinical laboratory), hospital market segment (by public & private hospitals, by general & specialty hospitals and by region), pharmaceutical market segment (by therapeutic segment, by domestic & international players, by generic & patented drug, by OTC & prescription drugs, by domestic sales & exports and by region), pharmacy retail market segment (by pharmacies & drugstores and by region), clinical laboratory market segment (by type of clinical laboratory, by type of private independent laboratory, by type of customer, by payer, by type of test and by region) and medical device market segment (by type of medical device, by type of medical consumables, by end user and by procurement), competitive landscape of major Hospitals (Mitra Keluarga Karyasehat Tbk Pt, Siloam Hospitals, PT Sejahteraraya Anugrahjaya, Sarana Meditama, Rumah Sakit Pondok Indah, Surya Husadha, Jakarta Eye Center), pharmaceutical companies (PT Kalbe Farma, PT Sanbe Farma, PT SOHO Global Health, PT Dexa Medica, PT Pharos, PT Kimia Farma, PT Tempo Scan Pacific, PT Merck), Pharmacy Retail (Guardian Pharmacy, Kimia Farma, Apotek K-24, A S Watsons, Century Healthcare), Diagnostic Laboratories (Prodia, Kimia Farma Diagnostika, Pramita, Cito, BioMedika, Parahita), Medical Devices Companies (GE Healthcare Indonesia, Siemens Indonesia, Philips Indonesia, PT Mensa Binasukses, PT Transmedic Indonesia). The report concludes with market projection for future and analyst recommendations highlighting the major opportunities and cautions.

Indonesia Healthcare Market Overview: Indonesia Healthcare market revenue has increased from USD ~ billion in 2012 to USD ~ billion in 2017. The healthcare market has increased on the account of increasing healthcare facilities, innovation in pharmaceutical manufacturers and clinical laboratory services and expansion of pharmacy retail chains across the country.

Market Segmentation

Indonesia Hospital Market: Indonesia Hospital Market grew from USD ~ million in the year 2012 to USD ~ million in the year 2017. Public hospitals have accounted for ~% of the number of hospitals on account of the increase in the government budget allocation on healthcare. Private hospitals have registered ~% of the total hospitals in Indonesia in 2016 as the demand for modern medicine and specialist services increased in the country.

By General and Specialty Hospitals: General hospitals have accounted for ~% of the total number of hospitals whereas specialty hospitals which include hospitals such as mental hospitals, leprosy hospitals, eye hospitals, and others have registered ~% of the total number of hospitals.

Indonesia Pharmaceutical Market: Indonesia's Pharmaceutical market has registered an increase in the revenue at a CAGR of ~% from USD ~ billion in 2012 to USD ~ billion in 2017.

By Therapeutic Segment: Anti-infective drug sale has contributed to the largest share of ~% in the revenue share of Indonesia Pharmaceutical industry in 2017. This is followed by Gastrointestinal and metabolism drugs with ~%, cardiovascular system drugs with ~%, Central Nervous system drugs with ~%, Respiratory system drugs with ~%, Musculoskeletal system drugs with ~%, dermatology drugs with ~%, genitourinary and hormonal drugs with ~%, blood-related drugs with ~%, oncology with ~% and rest of the therapeutic segments with ~% of the revenue share in 2017.

By Domestic and International Players: Domestic players have accounted for ~% of the revenue in the Indonesia pharmaceutical market in 2017 driven by the implementation of JKN (National Health Insurance System) in 2014. International players have captured ~% of the revenue share in 2017 driven by favorable government norms for foreign ownership.

By Generic and Patented Drug: Generic drugs have accounted for the major revenue share of ~% in 2017 driven by the increased demand from government-run hospitals and clinics. The share of patented drugs has increased from ~% in 2013 to ~% in 2017. Further, ethical generic drugs have accounted for ~% of Indonesia generic drug market revenue in 2017 followed by free sale drugs with ~% and unbranded drug sales with ~%.

Indonesia Pharmacy Retail Market: Indonesia's pharmacy retail market revenue has escalated from USD ~ billion in 2012 to USD ~ billion in 2017 at a CAGR of ~%.

By Pharmacies and Drugstores: Pharmacies have registered ~% of the revenue share in the Indonesia pharmacy retail market 2017 driven by higher margins and a wider portfolio of pharmacies. The drugstores which are licensed to sell only medicinal drugs have accounted for ~% in 2017.

By Region: West Java has accounted for ~% of the total number of pharmacies and drugstores located in Indonesia in 2015 driven by high population in the region and presence of generic drug manufacturers. This is followed by East Java with ~%, Central Java with ~%, Jakarta with ~% and North Sumatra with ~% of the pharmacies and drugstores in Indonesia in 2015. The rest of Indonesia has accounted for ~% of the drugstores.

Indonesia Clinical Laboratory Market: Indonesia's clinical laboratory market increased from USD ~ million in 2012 to USD ~ million in 2017 at a CAGR of ~%.

By Type of Laboratory: The public clinical labs have accounted for ~% of the revenue share in the Indonesia clinical laboratory market in 2017. Private hospital labs have accounted for ~% in 2017 and private independent labs with ~% of the overall market.

By Type of Private Independent Laboratory: The laboratory chains such as Prodia, Kimia Farma Diagnostik, Pramita, Cito, BioMedika and Parahita have together accounted for ~% of the revenue the overall private independent laboratory market in 2016. Single independent labs have contributed to their lower revenue share of ~% due to their restricted geographic presence.

By Type of Tests in Private Independent Laboratory: Routine tests have accounted for ~% of the revenue in Indonesia Private independent laboratory market in 2016. This is followed by esoteric tests with ~% and nonlaboratory tests with ~% of the overall private independent laboratory market.

Indonesia Medical Device Market: Indonesia Medical device revenue increased from USD ~ billion in 2012 to USD ~ billion in 2017 at a CAGR of ~%

By Type of Medical Device: Diagnostic imaging products have accounted for the largest share of ~% of the revenue share in the Indonesia Medical Devices market in 2017. This is followed by medical consumable product with ~%, aesthetic devices with ~%, auxiliary devices with ~%, dental products with ~% and orthopedic implants with ~%. Others which include Point of Care Testing devices, radiation oncology devices, therapy system, and testing and measurement systems have accounted for ~% of the overall market revenue.

By Procurement: Imports have accounted for ~% of the revenue share in Indonesia Medical Device Market in 2017. The imports are largely related to more sophisticated medical and surgical instruments and infrastructure. The share of local companies in the market revenue has increased from ~% in 2014 to ~% in 2017.

Snapshot on Indonesia Polyclinic Market: Demand for various healthcare services in the country has escalated over the past five years owing to increased prevalence of various lifestyle-related diseases such as Diabetes, Obesity, Hypertension, Blood Pressure, Cardiovascular diseases and expanding population base of the country over the last five years has cemented the polyclinic market’s position as a major healthcare service provider in the country. The majority of people in Indonesia have preferred polyclinics over hospitals in the past few years due to convenience and lower cost of healthcare services. The number of Puskesmas in Indonesia has increased from ~ in 2012 to ~ in 2016.

Key Topics Covered in the Report:

Indonesia Healthcare, Hospitals, Pharmaceutical, Pharmacy Retail, Clinical Laboratory, Medical Devices Market Size, 2012-2017
Indonesia Hospitals Market Segmentation (by public & private hospitals, by general & specialty hospitals and by region)
Indonesia Hospitals, Pharmaceutical, Pharmacy Retail, Clinical Laboratory, Medical Devices Market Competitive Landscape
Indonesia Hospital, Pharmaceutical, Pharmacy Retail, Clinical Laboratory, Medical Devices Future Outlook and Projections, 2018-2022
Indonesia Pharmaceuticals Market Segmentation (by therapeutic segment, by domestic & international players, by generic & patented drug, by OTC & prescription drugs, by domestic sales & exports and by region)
Indonesia Pharmacy Retail Market Segmentation (by pharmacies & drugstores and by region)
Indonesia Clinical Laboratory Market Segmentation (by type of clinical laboratory, by type of private independent laboratory, by type of customer, by payer, by type of test and by region)
Indonesia Medical Devices Market Segmentation (by type of medical device, by type of medical consumables, by end-user and by procurement)
Analyst Recommendations
Macro-economic Factors Impacting Indonesia Healthcare Market

Products

Demand for healthcare services in the market will continue to grow in Indonesia owing to favorable government regulations for FDI inflows, rising prominence of health tech startups, increased focus on biopharmaceuticals and nutrition and dietary supplements.

Companies

Hospitals (Mitra Keluarga Karyasehat Tbk Pt,
Siloam Hospitals,
PT Sejahteraraya Anugrahjaya,
Sarana Meditama,
Rumah Sakit Pondok Indah,
Surya Husadha,
Jakarta Eye Center),
pharmaceutical companies (PT Kalbe Farma,
PT Sanbe Farma,
PT SOHO Global Health,
PT Dexa Medica,
PT Pharos,
PT Kimia Farma,
PT Tempo Scan Pacific,
PT Merck),
Pharmacy Retail (Guardian Pharmacy,
Kimia Farma,
Apotek K-24, A S Watsons,
Century Healthcare),
Diagnostic Laboratories (Prodia,
Kimia Farma Diagnostika,
Pramita, Cito, BioMedika, Parahita),
Medical Devices Companies (GE Healthcare Indonesia,
Siemens Indonesia,
Philips Indonesia,
PT Mensa Binasukses,
PT Transmedic Indonesia)

1. Executive Summary

Indonesia Healthcare Market Overview
Market Segmentation
Indonesia Hospital Market
Indonesia Pharmaceutical Market
Indonesia Pharmacy Retail Market
Indonesia Clinical Laboratory Market
Indonesia Medical Device Market
Snapshot on indonesia Polyclinic market

2. Research Methodology

2.1. Market Definitions
2.2. Abbreviations
2.3. Market Size and Modeling
Consolidated Research Approach
Market Sizing - Medical Devices Market
Market Sizing - Hospitals Market
Market Sizing - Clinical Laboratories Market
Market Sizing - Pharmaceutical Market
Market Sizing - Pharmacy Retail Market
Variables (Dependent and Independent)
Multi Factor Based Sensitivity Model
Final Conclusion

3. Indonesia Healthcare Market, 2012-2017

3.1. Indonesia Healthcare Statistics
3.2. Universal Health Coverage and Health Care Financing Indonesia
3.3. Indonesia Healthcare Insurance
3.4. Indonesia Healthcare Value Chain
3.5. SWOT Analysis for Indonesia Healthcare Market
3.6. Indonesia Healthcare Market Size, 2012-2017
3.7. Indonesia Healthcare Segmentation
3.7.1. By Hospitals, Pharmaceuticals, Medical Devices and Clinical Laboratory, 2012-2017

4. Indonesia Hospital Market Overview and Genesis

4.1. Indonesia Hospital Market Size, 2012-2017
4.2. Indonesia Hospital Market Segmentation
4.2.1. By Public and Private Hospitals, 2012-2016
4.2.2. By General and Specialty Hospitals, 2012-2016
By Type of Specialty Hospitals on the Basis of Number of Hospitals and Beds, 2012-2015
4.2.3. By Region, 2016
4.3. Business Model for Indonesia Hospital Market
4.4. Trends and Developments in Indonesia Hospital Market
Rising Foreign Investment
Implementation of Universal Health Coverage Programme
Increasing Prevalence of Chronic Diseases
Increase in Hospitals and Clinics
Rising number of Private Hospitals
Rising Adoption of Technology Enabled Healthcare Services in Indonesia
4.5. Issues and Challenges
Lack of Qualified Doctors and Nurses
Low Bed to Population Ratio
4.6. Government Initiatives, Rules and Regulation In Indonesia Hospital Market
4.7. Major Hospital Projects in Indonesia Hospital Market
4.8. Competitive Landscape of Major Hospital Chains in Indonesia Hospital Market
4.9. Company Profiles
4.9.1. Mitra Keluarga Karyasehat Tbk PT
4.9.2. Siloam Hospitals
Case Study on Siloam Hospitals Located in Purwakarta, Java
Demand Analysis for Siloam Hospitals Located in Purwakarta, Java
4.9.3. PT Sejahteraraya Anugrahjaya
4.9.4. Sarana Meditama
4.9.5. Rumah Sakit Pondok Indah
4.9.6. Surya Husadha General Hospital
4.9.7. Jakarta Eye Center
4.9.8. Other Company Profiles
4.10. Indonesia Hospitals Future Outlook and Projections by Revenue, 2018-2022
4.11. Analyst Recommendations

5. Indonesia Pharmaceutical Market Introduction

5.1. Indonesia Pharmaceutical Market Size, 2012-2017
5.2. Indonesia Pharmaceutical Market Segmentation, 2017
5.2.1. By Therapeutic Segments (Anti-Infectives, Gastrointestinal and Metabolism, Cardiovascular System, Central Nervous System, Respiratory, Musculoskeletal, Dermatology, Genitourinary and Hormones, Blood, Oncology and Others), 2015 & 2017
Vitamins and Dietary Supplements Market, 2012-2017
5.2.2. By Domestic and International Players, 2012-2017
5.2.3. By Generic and Patented Drug, 2017
By Type of Generic Drugs (Unbranded, Ethical and Free Sales), 2013 and 2017
5.2.4. By OTC and Prescription Drugs, 2012-2017
5.2.5. By Domestic Sales and Exports, 2012-2016
5.2.6. By Region (West Java, East Java, Central Java, Jakarta and Others), Dec 2016
5.3. Trends, Developments and Restraint in Indonesia Pharmaceutical Market
Growth in Indonesia Animal Pharmaceutical and Vaccine Market
Increased Government Support
Rise in Mergers and Acquisitions Activities
Growing Investment from Foreign Companies
Dependence on Imports for API (Active Pharmaceutical ingredient) Procurement
Other Challenges Faced
5.4. Government Regulations for Indonesia Pharmaceutical market
Pharmaceutical Finished Products Registration Requirement
Registration Procedure
Pharmaceutical Raw Materials
Advertising and Distribution
FDI in Pharmaceutical Industry
Procedure of Applying for Patent in Indonesia
Import Regulations
Draft Law on Monitoring of Pharmaceutical Supply, Medical Devices and Household Health Products
Draft law on Hala Product Guarantee
Regulations for Non-Indonesian Stakeholders Planning to Enter the Pharmaceutical Market
5.5. Indonesia Biopharmaceutical Industry Snapshot
Innogene Kalbiotech
5.6. Snapshot on Indonesia Vaccine Market
5.7. Competitive Scenario for Major Players in Indonesia Pharmaceutical Market
5.8. Market Share of Major Players in Indonesia Pharmaceutical Market, 2015
5.9. Competitive Landscape of Major Players in Indonesia Pharmaceutical Market
5.9.1. PT Kalbe Farma
Product Portfolio for PT Kalbe Farma
5.9.2. PT Sanbe Farma
Product Portfolio for PT Sanbe Farma
5.9.3. PT SOHO Global Health
5.9.4. PT Dexa Medica
Product Portfolio for Dexa Medica
5.9.5. PT Pharos
Product Portfolio for PT Pharos
5.9.6. PT Kimia Farma
Product Portfolio for PT Kimia Farma
5.9.7. PT Tempo Scan Pacific Tbk
Product Portfolio for PT Tempo Scan Pacific Tbk, Indonesia
5.9.8. PT Merck Tbk
5.9.9. Overview for Other Major Players (Fahrenheit, Sanofi Aventis, PT. Novell Pharmaceutical Laboratories, Biofarma, Darya Varia and Konimex) in Indonesia Pharmaceutical Market
5.10. Indonesia Pharmaceutical Market Future Outlook and Projections, 2018-2022
5.10.1. By Therapeutic Segments (Anti Infectives, Gastrointestinal and Metabolism, Cardiovascular System, Central Nervous System, Respiratory, Musculoskeletal, Dermatology, Genitourinary and Hormones, Blood, Oncology and Others), 2022
5.10.2. By Generic and Patent Drugs, 2022
5.11. Analyst Recommendations

6. Indonesia Pharmacy Retail Market Introduction

6.1. Indonesia Pharmacy Retail Market Size by Revenue and Number of Pharmacies, 2012-2017
6.2. Indonesia Pharmacy retail Market Segmentation
6.2.1. By Pharmacies and Drugstores, 2012-2017
6.2.2. By Region on the basis of Number of Pharmacies and Drugstores (Central Java, East Java, West Java, North Sumatra, Jakarta and Others), 2015
6.3. Value Chain
Margin Analysis
6.4. Trends and Developments in Pharmacy Retail Market
Indonesia Encouraging Investments from Foreign Companies
Emergence of Science and Technology Parks
Surging imports of Drugs
Increased Life Expectancy and Ageing Population
High Prevalence of Lifestyle- Related Diseases
Growth in Online Retail
6.5. Competition Scenario in Indonesia Pharmacy Retail Market
6.6. Competitive Landscape of Major Organized Pharmacy Chains in Indonesia
6.6.1. Guardian Pharmacy
6.6.2. Kimia Farma
6.6.3. Apotek K-24
6.6.4. A S Watsons group
6.6.5. Other Major players (Century Healthcare)
6.7. Indonesia Pharmacy Retail Market Future Outlook and Projections, 2018-2022
6.7.1. By Pharmacies and Drugstores
6.8. Analyst Recommendation

7. Indonesia Clinical Laboratory Market Introduction

7.1. Indonesia Clinical Laboratory Market Size, 2012-2017
7.2. Indonesia Clinical Laboratory Market Segmentation
7.2.1. By Type of Laboratory (Public Clinical Lab, Private Hospital Labs and Private Independent Labs), 2012-2017
7.2.2. Indonesia Private Independent Laboratory Market Segmentation
By Type of Private Independent Laboratory (Laboratory Chains and Single Independent Laboratory), 2015 & 2016
By Type of Customer (Doctor Referrals, Walk-Ins, Corporate Clients and External Referrals), 2016
By Payer (Private Health Insurance, Corporates, Out of Pocket and BPJS), 2016
By Type of Test (Routine, Non Laboratory and Esoteric), 2016
By Region, 2016
7.3. Value Chain of Clinical Labs Market
7.4. Trends, Developments, Issues and Challenges in Indonesia Clinical Laboratory Market
Universal Health Coverage (UHC) Increases The Demand For Clinical Laboratory Testing
Rising Prevalence of Non-Communicable Diseases (NCDs) and Communicable Diseases (CDs)
Increasing Demand For Health Check-Ups
Introduction of New Specialized Tests
Shortage of Skilled Human Resource Limits Growth
Limitations in Reimbursement per Case Load by BPJS May Limit the Extent of Tests Performed
Failure of Hub-and-Spoke Model
7.5. Government Regulations for Indonesia Clinical Laboratories Market
Classification And Licenses Of Clinical Laboratories
License Application Process
Regulation for Setting up Clinical Laboratory in Indonesia
Regulations on Transport of Tests and Quality Control Management
Regulation for Transporting Samples Abroad
Specimen Collection Point / Hospital Laboratory
Relevant Regulations On The Medical Personnel Law
Foreign Investment Restrictions
7.6. Competition Scenario for Indonesia Clinical Laboratories Market
7.7. Market Share of Major Organized Clinical Laboratories in Indonesia, 2016
7.8. Competitive Landscape of Major Organized Diagnostics Labs in Indonesia
7.8.1. Prodia
7.8.2. Kimia Farma Diagnostika
7.8.3. Pramita
7.8.4. Cito
7.8.5. BioMedika
7.8.6. Parahita
7.9. Indonesia Clinical Laboratory Market Future Outlook and Projections, 2018-2022
7.9.1. By Type of Private Independent Laboratory (Laboratory Chains and Single Independent Laboratory), 2022
7.9.2. By Type of Test (Routine, Non Laboratory and Esoteric), 2022
7.10. Analyst Recommendation

8. Indonesia Medical Device Market Introduction

8.1. Indonesia Medical Devices Market Size, 2012-2017
8.2. Indonesia Medical Devices Market Segmentation
8.2.1. By Type of Medical Devices (Medical consumable Products, Diagnostic Imaging Products, Auxiliary Devices, Orthopedic Implants, Dental Products, Aesthetic Devices and Others), 2014 and 2017
By Type of Medical Consumables (Syringes, Needles, Catheters, Bandages, Dressings, Suturing materials, Ostomy Products and Others), 2014 and 2017
8.2.2. By End Users (Hospitals, Clinics and Others), 2017
8.2.3. By Procurement (Imports and Domestic Production), 2014 and 2017
8.3. Regulatory Environment for Indonesia Medical Devices Market
Classification System for Medical Devices in Indonesia
Document Requirements for Medical Device Registration in Indonesia (MOH RI)
Other Special Requirements
Foreign Medical Devices Registration
Product Certification: SNI ISO 13485:2003
Electronic System to Control Medical Devices
Government Procurement
Import taxes and Duties
STandard Selling Requirement
8.4. Trends, Developments, Issues and Challenges in Indonesia Medical Devices Market
International manufacturers Register in e-catalogue
Rising Demand For More Sophisticated And Modern Medical Products
Challenges In Indonesia Medical Device Market
8.5. Competitive Scenario for Major Players in Indonesia Medical Devices Market
Decision Making Process to Shortlist Medical Device
8.6. Competitive Landscape of Major Players in Indonesia Medical Devices Market
8.6.1. Major Local Manufacturers
8.6.2. Major International Companies
GE Healthcare, Indonesia
Siemens, Indonesia
Philips, Indonesia
8.6.3. Major Local Distributors
PT Mensa Binasukses, Indonesia
PT Transmedic Indonesia
8.6.4. Overview for Other Major Local Distributors (PT Surgika Alkesindo, PT Daya Inti Kurnia Abadi)
8.7. Indonesia Medical Devices Market Future Outlook and Projections, 2018-2022
8.7.1. By Type of Medical Devices (Medical consumable Products, Diagnostic Imaging Products, Auxiliary Devices, Orthopedic Implants, Dental Products, Aesthetic Devices and Others), 2022
8.7.2. By Procurement (Imports and Domestic Production), 2022

9. Indonesia Polyclinic and Health Care Centers Market Snapshot, 2017

Public Health Services
Private Health Services

10. Indonesia Healthcare Industry Market Future Outlook and Projections, 2018-2022

11. Macro Economic Factors Affecting Indonesia Healthcare Market

11.1. Population, 2012-2022
11.2. Number of Primary Health Centers (Puskesmas), 2012-2022
11.3. Budget Allocation on Healthcare, 2012-2022
11.4. Obese Population, 2012-2022

Disclaimer Contact Us

Why Buy From Us?

Refine Robust Result (RRR) Framework

What makes us stand out is that our consultants follows Robust, Refine and Result (RRR) methodology. i.e. Robust for clear definitions, approaches and sanity checking, Refine for differentiating respondents facts and opinions and Result for presenting data with story

Our Reach Is Unmatched

We have set a benchmark in the industry by offering our clients with syndicated and customized market research reports featuring coverage of entire market as well as meticulous research and analyst insights.

Shifting the Research Paradigm

While we don't replace traditional research, we flip the method upside down. Our dual approach of Top Bottom & Bottom Top ensures quality deliverable by not just verifying company fundamentals but also looking at the sector and macroeconomic factors.

More Insights-Better Decisions

With one step in the future, our research team constantly tries to show you the bigger picture. We help with some of the tough questions you may encounter along the way: How is the industry positioned? Best marketing channel? KPI's of competitors? By aligning every element, we help maximize success.

Transparency and Trust

Our report gives you instant access to the answers and sources that other companies might choose to hide. We elaborate each steps of research methodology we have used and showcase you the sample size to earn your trust.

Round the Clock Support

If you need any support, we are here! We pride ourselves on universe strength, data quality, and quick, friendly, and professional service.

Why Client Choose Us?

400000+ Reports in repository

150+ Consulting project a year

100+ Analysts

8000+ Client Queries in 2022

Indonesia Healthcare Market Outlook to 2022

By Hospitals, Clinical Laboratories, Pharmaceutical, Pharmacy Chains, Medical Device Segment

About the Report

Market Segmentation

Key Topics Covered in the Report:

Products

Companies

Hospitals (Mitra Keluarga Karyasehat Tbk Pt,

Siloam Hospitals,

PT Sejahteraraya Anugrahjaya,

Sarana Meditama,

Rumah Sakit Pondok Indah,

Surya Husadha,

Jakarta Eye Center),

pharmaceutical companies (PT Kalbe Farma,

PT Sanbe Farma,

PT SOHO Global Health,

PT Dexa Medica,

PT Pharos,

PT Kimia Farma,

PT Tempo Scan Pacific,

PT Merck),

Pharmacy Retail (Guardian Pharmacy,

Kimia Farma,

Apotek K-24, A S Watsons,

Century Healthcare),

Diagnostic Laboratories (Prodia,

Kimia Farma Diagnostika,

Pramita, Cito, BioMedika, Parahita),

Medical Devices Companies (GE Healthcare Indonesia,

Siemens Indonesia,

Philips Indonesia,

PT Mensa Binasukses,

PT Transmedic Indonesia)

Table of Contents